Watchlist Price Alert

Grace Therapeutics Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

2.94

-0.02 (-0.68%)

At close: Jun 26, 2025, 3:56 PM

2.96

0.68%

After-hours: Jun 26, 2025, 05:52 PM EDT

Grace Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Cash & Equivalents	22.13M	23M	27.88M	30.34M	50.94M	14.24M	16.87M	6.37M
Short-Term Investments	n/a	n/a	15K	13.32M	9.79M	n/a	8.89M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	20K	20.13K
Other Long-Term Assets	15K	n/a	n/a	n/a	n/a	n/a	417K	429.76K
Receivables	126K	722K	802K	548K	530K	546K	1.19M	587.73K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	453K	n/a	n/a	352K	768K	2.7M	183K	80.53K
Total Current Assets	22.71M	24.01M	29.29M	45.28M	62.37M	18.46M	27.97M	7.35M
Property-Plant & Equipment	n/a	24K	567K	565K	86K	147K	2.11M	2.18M
Goodwill & Intangibles	49.27M	49.27M	49.27M	82.77M	n/a	4.24M	6.39M	7.79M
Total Long-Term Assets	49.28M	49.29M	49.83M	83.34M	86K	4.39M	8.93M	10.43M
Total Assets	71.99M	73.3M	79.12M	128.62M	62.46M	22.85M	36.9M	17.78M
Account Payables	n/a	1.01M	1.24M	1.68M	115K	1.71M	3.05M	2.65M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	1.36M	n/a
Other Current Liabilities	1.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	1.93M	1.68M	3.41M	3.26M	1.58M	7.39M	13.67M	5.19M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.25M
Other Long-Term Liabilities	1.14M	4.36M	n/a	10K	5.22M	2.39M	12.18M	4.98M
Total Long-Term Liabilities	3.45M	9.87M	7.76M	17.09M	5.22M	2.46M	12.18M	6.22M
Total Liabilities	5.38M	11.56M	11.17M	20.35M	6.8M	9.86M	25.85M	11.41M
Total Debt	n/a	n/a	485K	295K	86K	147K	1.36M	1.25M
Common Stock	1K	261.04M	258.29M	257.99M	197.19M	137.42M	110.86M	56.79M
Retained Earnings	-220.69M	-211.12M	-198.27M	-155.84M	-146.02M	-126.34M	-100.83M	-56.05M
Comprehensive Income	-6.04M	-6.04M	-6.04M	-6.04M	-6.33M	-7.89M	n/a	n/a
Shareholders Equity	66.61M	61.74M	67.95M	108.27M	55.66M	12.99M	11.04M	6.37M
Total Investments	n/a	n/a	15K	13.32M	9.79M	n/a	8.91M	20.13K